Photo of John Christodouleas from pc3i.upenn.edu
Nov 18, 2024, 17:46
John Christodouleas: 3 things I learned at the MR-Linac Consortium meeting in Singapore
John Christodouleas, Genitourinary Radiation Oncology at PENN Radiation Oncology Resident, shared on LinkedIn:
“3 things I learned at the MR-Linac Consortium meeting in Singapore:
1.Iron-corrected T1 mapping (cT1) is a non-contrast MR sequence that assesses liver fibrosis. It could aid functional liver-sparing planning, particularly in PULSAR approaches for HCC. (Shout out The Christie NHS Foundation Trust)
2.Large-volume brain metastases from NSCLC can shrink dramatically during hypofractionated RT and is another great indication for adaptive MRgRT. (Shout out CAMS in Beijing)
3.DWI/ADC kinetics show great potential as a biomarker to identify both who and where early GBM recurs after RT (shoutout Sunnybrook).”
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Nov 18, 2024, 17:40
Nov 18, 2024, 17:34
Nov 18, 2024, 17:31
Nov 18, 2024, 17:22
Nov 18, 2024, 17:20
Nov 18, 2024, 17:13
Nov 18, 2024, 16:55